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A patient with long-standing cirrhosis due to hepatitis C and hepatic hydrothorax was evaluated for
increasing symptoms and presence of a large right pleural effusion. Thoracentesis revealed evidence of a
chylothorax with rapid reaccumulation of pleural ﬂuid. Repeat thoracentesis with manometry identiﬁed
presence of entrapped lung which complicated treatment options. This is the ﬁrst case report of a hepatic
chylothorax with features of entrapped lung.
© 2016 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A chylothorax is a well described pleural effusion characterized
by the presence of triglycerides (>110 mg/dL) or chylomicrons in
the pleural ﬂuid. Malignancies, most commonly lymphoma, chronic
lymphocytic leukemia, and metastatic cancer, are the leading cau-
ses of non-traumatic chylothorax [1]. Less frequently, chylothorax
can be found in cirrhotics with chylous ascites where ﬂuid leaks
across the diaphragm into the pleural space; it may also be reported
in conjunctionwith heart failure and the nephrotic syndrome [2,3].
Effusions due to chylous ascites are nearly always exudative though
in a few cases they may be transudative by Light's criteria such as
patients with amyloidosis, cirrhosis, nephrotic syndrome, superior
vena cava obstruction, heart failure, and chylous ascites. Effusions
related to chylous ascites are generally free-ﬂowing and reac-
cumulate rapidly after a therapeutic thoracentesis. Lung entrap-
ment results from an active pleural process, such as malignancy,
infection, or inﬂammation that leaves the visceral pleura unable to
fully expand after removal of an effusion. Lung entrapment is often
suspected clinically but pleural manometry is required to establishitary Medical Center, Internal
e Drive, JBSA Fort Sam Hous-
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inﬂammatory process, transudative chylothorax, complicated by
lung entrapment.2. Case report
A 67 year-old-female with chronic hepatic cirrhosis secondary
to hepatitis C was evaluated in our pulmonary clinic for complaints
of worsening exertional dyspnea and bilateral lower extremity
edema. She had been diagnosed with a hepatic hydrothorax three
years prior but had minimal ascites and concurrent pleural effu-
sions were well managed with outpatient diuretic therapy con-
sisting of furosemide and spironolactone. During the preceding
month, her ascites had been recalcitrant to increases in diuretic
therapy; she became progressively more dyspneic and had twice
required therapeutic drainage of a recurring right sided pleural
effusion.
On physical exam she was a frail, elderly female with diffuse
spider angiomas on her upper torso and absent breath sounds over
her right lower lung ﬁeld. Abdominal distensionwas not noted, but
she did have mild bilateral lower extremity edema. Repeat thera-
peutic thoracentesis was performed and was terminated when she
experienced chest tightness and cough. Concurrent pleural
manometry demonstrated a rapid drop in the pleural elastance at
the time her symptoms began (Fig. 1).BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Pleural manometry during thoracentesis. Legend: Pleural manometry demon-
strating the presence of lung entrapment with relatively normal initial elastance curve
followed by a sharp drop in pressure due to inability of lung to expand.
S.C. Owen et al. / Respiratory Medicine Case Reports xxx (2016) 1e32Subsequent post procedure ultrasound and chest X-ray showed
no pneumothorax but did reveal a large residual effusion. The
pleural ﬂuid appeared turbid and milky while laboratory analysis
was consistent with a transudative effusion with elevated tri-
glycerides (Table 1).
There was no antecedent trauma, surgery, evidence of conges-
tive heart failure, signs of nephrotic syndrome or any other obvious
etiology for the chylothorax. Computed tomography scan of the
chest revealed no evidence of malignancy, adenopathy or
anatomical derangements. Abdominal ultrasound with Doppler
ﬂow showed no hepatic vein obstruction. In the ensuing weeks she
underwent a steady clinical decline secondary to progressive liver
failure. She developed hepatorenal syndrome and was unable to
tolerate further diuretic therapy due to declining kidney function.
She was ineligible for a transjugular intrahepatic portosystemic
shunt due to her concurrent encephalopathy. After being evaluated
and not deemed a candidate for orthotopic liver transplantation,
she elected to have an indwelling pleural catheter placed and was
discharged home with hospice.3. Discussion
Classically described as a turbid, milky appearing ﬂuid second-
ary to elevated chylomicrons and triglycerides, a chylothorax can
also appear serous, serosanguinous or even bloody [3]. The het-
erogeneity in appearance of chylous effusions may lead to under-
diagnosis as triglyceride levels are not routinely measured.Table 1
Comparison of pleural ﬂuid studies from 2010 to 2013.
Year 2010 20
Color Straw Cre
pH 7.71 7.6
Pleural ﬂuid (PF) protein (g/dL) 1.5 0.5
Serum total protein (g/dL) 7.1 6.7
PF/Serum protein ratio 0.21 0.0
PF Lactate Dehydrogenase (LDH) (IU/L) 87 30
Serum LDH (IU/L) 205 15
PF/Serum LDH ratio 0.42 0.1
PF Glucose (mg/dL) 90 13
PF Triglyceride (mg/dL) 5 59
PF Cholesterol (mg/dL) Not measured 34
Bacterial Culture Negative Ne
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duct and have traditionally been classiﬁed by the underlying eti-
ology: trauma; malignancy (most commonly lymphoma), idio-
pathic, and miscellaneous [8]. The vast majority of chylous
effusions are exudative in nature.
Transudative chylothoraces have been associated with conges-
tive heart failure, cirrhosis, amyloidosis, obstruction of the superior
vena cava, and the nephrotic syndrome; however, the majority of
these effusions have been associated with underlying cirrhosis
[2,3,9]. The pathophysiology is believed to be elevated intra-
abdominal pressures in conjunction with degenerative changes in
splanchnic lymphatics resulting in lymph leakage into the perito-
neal cavity. The transudative properties are likely secondary to
dilution in concurrently forming portal hypertension ascites [10,11].
A preexisting anatomical defect allows this ﬂuid to freely cross the
diaphragm, a process expedited by the lower pressures found in the
pleural cavity. Hence a chylous peritoneal effusion becomes a
chylous hepatic hydrothorax [2]. In our patient, the rapid reac-
cumulation was further accelerated by decreased intrapleural
pressures from her entrapped lung. Although there have been re-
ports of transudative hepatic hydrothorax that subsequently
became exudative following secondary bacterial infection, to the
authors' knowledge there has been only one case report of such an
event involving a hepatic chylothorax [12]. The reason for the low
propensity for secondary infection is presumed to be the inherent
bacteriostatic nature of chyle [13].
The transudative effusion in the setting of lung entrapment is a
unique feature in this case. Patients with an entrapped lung are
usually symptomatic on presentation and have exudative effusions
in the vast majority of cases [5]. Chest discomfort often occurs
during thoracentesis despite a considerable amount of residual
ﬂuid [14,16]. There have been no prior reported cases of lung
entrapment following from a transudative chylothorax. Trapped
lung results from previous pleural inﬂammation resulting in
ﬁbrosis and scarring of the visceral pleura. The inciting event is
typically an infectious process such as pneumonia although alter-
nate etiologies such as hemothorax, pneumothorax, thoracic cavity
interventions, uremia and rheumatoid pleuritis have been reported
[5e7]. The inability of the affected lung to expand results in
excessive negative intrathoracic pressures with subsequent devel-
opment of an effusion ex vacuo [15]. These effusions are always
transudative and patients are typically asymptomatic or may
complain of dyspnea due to the restrictive effects of the unex-
pandable lung [5].
The unexpandable lung is diagnosed via pleural manometry.
This involves intermittent measurement of pressure in the pleural
space during thoracentesis. The data points aremapped as a change
in pressure over change in volume to create a pleural elastance
curve. While several different methods of measuring the13 Interpretation (per lights criteria [8])
am, turbid
9
7 Ratio > 0.5 classiﬁed as exudative
LDH > 2/3s the upper limit of normal (148.5 IU/L)
1
9 Ratio > 0.6 classiﬁed as exudative
1
9 Triglyceride > 110 mm g/dL classiﬁed as a chylothorax
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S.C. Owen et al. / Respiratory Medicine Case Reports xxx (2016) 1e3 3intrapleural pressure, the concept of measuring the change in
pulmonary elastance is the same for all methods [5,14,16] Three
classic elastance curves were described by Light et al. [17]. In a
normal pressure curve there is an initial positive pressure with an
almost linear drop in pressure as volume is removed. Lung
entrapment produces an initially normal curve with a sharp
negative descent once the lung is unable to expand further. Patients
with trapped lung demonstrate an initially negative pleural pres-
sure with a steady, rapid drop in pressure during thoracentesis. It
has been proposed that the longstanding active inﬂammation that
results in lung entrapment leads to development of pleural ﬁbrosis
and subsequent trapped lung that persists after resolution of the
initial insult [5,15]. This would imply that lung entrapment and
trapped lung are on a spectrum of pleural disease rather than
distinct entities as initially suggested by Light's pleural manometry
data.
4. Conclusion
There are several unique characteristics of this case that have
not been previously reported. Transudative chylothoraces are
exceedingly rare entities most commonly occurring in patients
with chronic cirrhosis and hepatic hydrothorax. They have never
been previously described in association with entrapped lung.
Though an extensive workup was performed, no inﬂammatory
etiology was ever discovered. The presence of the entrapped lung
appearing at the same time as the identiﬁcation of the chylothorax
suggests it may have contributed to the underlying process. Alter-
natively, it is possible the patient had another inﬂammatory pleural
process that developed between her initial thoracentesis and sub-
sequent follow up that predisposed her to development of an
entrapped lung. Clinicians should have a low threshold to measure
triglyceride levels in patients with known hepatic hydrothorax and
consider the use of manometry during thoracentesis.
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